Supplementary Tables for: Identification and Clinical Validation of CDKN2A Copy Number Loss Driving Progression in Renal Cell Carcinoma

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Xiaowen Wu
DOI: 10.5281/zenodo.18221278
Cited by: 0

Abstract

This record contains all Supplementary Tables (S1–S7) supporting the analyses presented in the associated manuscript.

Fields of Study & Subjects

Renal cell carcinoma treatment Cancer Genomics and Diagnostics Chromatin Remodeling and Cancer

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
12 January 2026